Join Ken Mulvany Founder and Chairman of BenevolentAI for a talk on "Can a machine cure brain disease"
Jackie Hunter, CEO BenevolentBio and Jerome Pesenti, CEO BenevolentTech will be joining Web Summit this year.
Patrick Keohane, Chied Medical Officer at BenevolentBio will be presenting at the BioData World Congress 2017
Join Jerome Pesenti, CEO BenevolentTech at Founder Forum for a panel on Artificial Intelligence
Jerome Pesenti, CEO at BenevolentTech will be joining Data Driven Event held at Bloomberg LP to discuss how BenevolentAI artificial intelligence can accelerate drug discovery
Big Data is the process of analysing high volume, high velocity data by advanced computational methods that produce actionable knowledge...
Dan Neil, Lead Machine Learning Researcher at BenevolentAI discusses Tools, Frameworks and AI Systems Engineering: Survey of Tools and Frameworks
Jerome Pesenti, CEO BenevolentTech participated to the G7 debate around around challenges that innovation poses.
The AI in Bioscience Symposium is an annual one day conference that aims to foster collaboration between experts in AI, technology, academia and the life sciences industry
BenevolentAI will be sponsoring MLSB Workshop on Machine Learning in Systems Biology. Our team will be present and we encourage to get in touch. Job opportunities are opened.
Translating UK scientific excellence in global therapeutics strategies
Join the second meet-up of the Special Interest Group on Artificial Intelligence in Biomedicine
Join Jérôme Pesenti on a panel about the impact of artificial intelligence on healthcare at Cognition X event
Meet Jérôme Pesenti, CEO BenevolentTech at Viva Technology in Paris
Join Mark Davies for a breakfast on Tuesday 6th June at the Hospital Club and hear from a panel of AI industry experts with first-hand experience building, funding and exiting successful AI companies.
The future of science innovation: building collaborations between academia start-ups and industry
Join a select group of 250 practitioners, researchers, entrepreneurs and investors to explore current and future industry applications of groundbreaking new technologies in healthcare.
Solving the world’s most pressing challenges through open innovation and partnership.
Only 1 in 5,000 medicines in development make it to market, with a drug typically taking 12 years to develop from initial discovery to market. Estimates vary but the Association of the British Pharmaceutical Industry puts drug development at £1.15bn per drug.
BenevolentAI Team will be attending the event, get in touch!
Join fellow developers, startups, academics and investors at the second edition of Project Juno's event to highlight the breadth and depth of machine intelligence activity and talent in Europe.
Professor Jackie Hunter has been invited to speak at this year's TechCrunch Disrupt event in London
NIPS is coming to Europe between 5th and 10th December in Barcelona – meet us there, talk to us about the world of AI and maybe joining the team